For example, a known LRA, ingenol, is isolated originally from Euphorbia peplus [64] and is a US-FDA-approved topical treatment for actinic keratosis (AK) [65], showed a significant effect in the reactivation of HIV-1 latency through the PKC pathway [65]. The gene discussed is PRRT2; the disease is actinic keratosis.